Biolife Solutions (BLFS) Total Non-Current Liabilities (2010 - 2026)
Biolife Solutions' (BLFS) quarterly Total Non-Current Liabilities came in at $28.5 million in Q1 2026, down 15.76% on a QoQ basis from $33.8 million in Q4 2025.
Biolife Solutions (BLFS) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends
Biolife Solutions (BLFS) has 15 years of Total Non-Current Liabilities data on file, last reported at $28.5 million in Q1 2026.
- On a quarterly basis, Total Non-Current Liabilities changed N/A year-over-year to $28.5 million in Q1 2026; TTM through Mar 2026 was $28.5 million, a N/A change from a year earlier, with the FY2025 full-year figure at $33.8 million, down 33.12% from the prior year.
- Total Non-Current Liabilities for Q1 2026 stood at $28.5 million, down from $33.8 million in the prior quarter.
- Over the last five years, Total Non-Current Liabilities for BLFS reached as high as $88.4 million in Q1 2023 and fell as low as $28.5 million in Q1 2026.
- Historically, Total Non-Current Liabilities has averaged $66.1 million across 5 years, with a median of $75.1 million in 2023.
- Across the five-year window, Total Non-Current Liabilities soared 125.1% in 2022 and tumbled 33.12% in 2025, its largest moves.
- Year by year, Total Non-Current Liabilities stood at $83.7 million in 2022, then decreased by 10.36% to $75.1 million in 2023, then sank by 32.61% to $50.6 million in 2024, then plunged by 33.12% to $33.8 million in 2025, then fell by 15.76% to $28.5 million in 2026.
- Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $28.5 million in Q1 2026, $33.8 million in Q4 2025, and $50.6 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 6.48 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 1.92 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 48.37 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 17.13 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 941.16 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 996.30 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 4.24 Bn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 8.65 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 2.06 Bn |
| 10 | Biolife Solutions | 1.50 Bn | 1.42 Bn | 17.50 Mn | 28.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 28.49 Mn |
| Dec 31, 2025 | 33.83 Mn |
| Dec 31, 2024 | 50.58 Mn |
| Dec 31, 2023 | 75.05 Mn |
| Sep 30, 2023 | 78.77 Mn |
| Jun 30, 2023 | 79.14 Mn |
| Mar 31, 2023 | 88.36 Mn |
| Dec 31, 2022 | 83.72 Mn |
| Sep 30, 2022 | 79.71 Mn |
| Jun 30, 2022 | 61.04 Mn |
| Mar 31, 2022 | 68.13 Mn |
| Dec 31, 2021 | 76.20 Mn |
| Sep 30, 2021 | 64.61 Mn |
| Jun 30, 2021 | 63.16 Mn |
| Mar 31, 2021 | 30.27 Mn |
| Dec 31, 2020 | 29.51 Mn |
| Sep 30, 2020 | 8.77 Mn |
| Jun 30, 2020 | 7.74 Mn |
| Mar 31, 2020 | 25.38 Mn |
| Dec 31, 2019 | 9.76 Mn |